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Abstract
The paper presents a new robotic system for beating heart surgery. The final goal of this
project is to develop a tele-operated system for the thoracoscopic treatment of patients with
atrial fibrillation. The system consists of a robot that moves an innovative end-effector used
to perform lines as in the Cox-Maze technique. This device is an electrode mesh that is
introduced in the thorax through a trocar and is deployed inside the left atrium, where it
can create selective ablation lines at any atrial region, using radio frequency. The current
version of the umbrella has 22 electrodes. Using visual feedback from an ultrasound based
navigation system, the surgeon can choose which electrodes on the mesh to activate. Once
the umbrella is in contact with the endocardium of the left atrium, at the expected position,
the surgeon activates the chosen electrodes sequentially. The umbrella can then be moved to
another position. In vitro and in vivo animal tests have been carried out in order to test and
improve the instrument, the robotic system and the operative procedure.
Keywords: surgical robotics, heart surgery, RF ablation, PDMS.
Introduction
Atrial fibrillation is a widespread heart arrhythmia. Several treatments already exist based on
drugs or on surgery. This paper deals with a novel minimally invasive instrument developed
for the beating heart atrial fibrillation surgical treatment performed with the assistance of a
robotic system.
In this field, several surgical robots exist. The product to date from Computer Motion
is the Zeus minimal invasive surgical robot system used for endoscopic cardiac intervention
like coronary artery bypass grafting(1). Intuitive Surgical provides the da Vinci or da Vinci S
surgical system also for minimal invasive cardiac intervention. The Robodoc from Integrated
Surgical Systems is more specialized in preparing bones for prosthetic implants. Theses robots
are equipped of minimal invasive instruments like graspers, scissors, scalpels, cautery instru-
ments, etc. witch are miniaturization of the classical instrument used in invasive surgery.
The aim of this research is to develop a device, with a design inspired from the left atrium
morphology, that is inserted in it, allowing the surgeon to plan and achieve ablation lines
anywhere in the endocardium. The ablation lines are obtained by the activation of different
independent electrodes that are positioned as desired by the robotic system. Finally, abla-
tion lines will block multiple re-entrant electrical signals that move randomly throughout the
muscular cells of the atria, in atrial fibrillation.
1 Subject presentation
1.1 Atrial fibrillation
Atrial Fibrillation (AF) is the most common heart arrhythmia and results basically from
multiple re-entrant electrical signals that move randomly throughout the atria’s muscular
cells. Classically, electrical re-entrant impulses are associated with decreased atrial refractory
periods, decreased electrical conduction speed and increase in the atria’s muscular volume.
More recently it has been demonstrated that AF changes atrial electric properties resulting in
a potential self-perpetuating phenomenon(2).
AF affects about 1 in 20 people above 60 years old and its prevalence is on the rise in our
aging population(3). Affecting almost 1% of the general population in USA, its prevalence is
expected to rise 2.5 - fold by 2050(3).
AF related overall costs are very significant. It has been estimated in USA that these costs
are between US $9300 and $18900 per patient / year, while in the UK they represents about
1% of all National Health Service expenditure(2, 3).
The major complications in patients with AF are thromboembolic accident related, in-
creased heart failure rate, higher stroke incidence and increased mortality rate(2, 3).
AF is associated with a significant decrease in quality of life, which can be improved by
restoring sinus rhythm(4).
In the currently accepted classification, two or more episodes of AF is termed recurrent
AF. Recurrent AF can be paroxysmal (attacks spontaneously end after 7 days or less), per-
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sistent (requiring electric or pharmacological cardioversion) or permanent (no sinus rhythm
permanently sustained after cardioversion)(5).
It has been demonstrated that with the use of antiarrhythmic drugs, sinus rhythm can be
maintained in only 50% to 65% of the patients(2).
1.2 Therapy evolution
For those patients whose sinus rhythm cannot be maintained with drug therapy and those
whose who have other problems such as drug intolerance, alternative treatments have been
tried, including surgical approaches(2). The first surgical procedure developed for atrial fib-
rillation (AF) management was the ”corridor” procedure in 1985, where, in an open heart
intervention, sutures were used to isolate the atrial free wall from the septum, forcing the elec-
trical pulses to pass in a pathway (the ”corridor”) from sinus node to atrioventricular node(2).
This technique proved to be a long term relatively ineffective method, as about 27% of the
patients later developed other atrial arrythmia(2). In 1987, Cox introduced a new open heart
surgical technique, the ”maze” procedure(6–10). In this procedure, performed under cardiopul-
monary bypass, the left atrial appendage is excised, ablation lines are created around the
pulmonary veins, and a sophisticated circuit of blocking lines is formed in order to canalise
the electric pulses from the sinus node to the atrioventricular node. This eliminate large
potentially re-entrant regions and defines a maze-like ablation pattern(4). In almost 5 years
experience, Cox claimed a 98% effectiveness with this technique in treating atrial fibrillation
and restoring atrioventricular synchrony(11). However, the Cox-Maze procedure is extremely
invasive, as it needs the heart to be stopped and requires the use of cardiopulmonary by-
pass(4). In addition, the Cox-Maze procedure has a 2% - 3% perioperative mortality rate and
is characterised by potential complications, such as sinus node dysfunctions(2). Currently, the
procedure has been modified twice, to improve the results and simplify the complexity of the
technique, giving it the name of the Cox-Maze III procedure(5).
More recently, Cox-Maze III surgery has been compared with a technique in which a sim-
ilar pattern of lesions is created using a radio frequency device. The results are almost the
same, proving that radio frequency is an effective and easier method of creating ablation lines
in an open heart procedure(12). Another group of 132 patients underwent open heart radio
frequency (RF) ablation and the technique was shown to be safe and very effective in restoring
long term sinus rhythm(13).
Further interest in atrial fibrillation mechanism lead Haissaguere et al. to search for spon-
taneous initiation of AF. He discovered that about 64% of the patients studied presented a
unique point of origin, around the pulmonary veins, and to report a large percentage of ec-
topic foci(14). In their study, the patients had been treated by beating heart radio frequency
catheter ablation and 62% had no AF recurrence. Another study showed that isolation of
pulmonary veins by RF catheter ablation in a beating heart, in patients with paroxysmal AF,
can achieve a 70% success rate, when associated with the use of antiarrhythmic drugs(15). A
more recent study from Haissaguere and al. (2003) showed that following operator learning
curve, a rate of 70% effectiveness can be achieved by beating heart RF catheter ablation
around the pulmonary veins, and that a 5% additional success rate can be obtained in chronic
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Figure 1: complete surgical system.
AF by creating extra ablation lines(16). These results suggest that, on the one hand, catheter
ablation needs a skilled operator and, on the other hand, that 70% effectiveness may be the
maximum for ablation around pulmonary veins only.
Some others limitations of RF catheter ablation are that for obtaining effective ablation
lines, the contact between the electrodes and the tissue must be optimal and constant, which is
difficult with these flexible devices(17). Another possible failure of current minimally invasive
RF devices is related to the difficulty of creating complete lesions lines which are necessary to
stop re-entrant impulses(18).
Finally, an even more recent device has been made to create RF ablation lines in a beating
heart with a different approach, namely: clamping circular regions externally from the heart
(epicardial ablation)(17). This technique is still limited to ablation in regions around vessels
of the heart and atrial appendage.
The ideal instrument should be able to use a minimally invasive technique, i.e. a beating
heart procedure, to create continuous and transmural ablation lines using RF which requires
a good and continuous contact between the electrode and tissue. It should also be possible to
accomplish ablation almost everywhere in the atrial cavity. The combination of such features
should lead the device to be as effective as the Cox-Maze open heart procedure. This is exactly
what the new micro robotic ablation device has been designed for.
2 Surgical system
To perform the ablation lines in the beating heart a multi-degrees of freedom surgical system
has been developed (see figure 1). The patient is placed on a table in a lateral position. The
surgeon control a robot arm to deploy and position the ablation device in the left atrium.
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Figure 2: atrium stabilization kinematic (left), ablation device kinematic (right).
The ablation lines are made with an RF generator and a saline solution cooling system. The
instrument and the anatomical landmarks are localized with the ultrasound echographic nav-
igation system.
The peripheral subsystems include an RF generator, connected to the ablation device via
an electronic unit which allows electrodes selection. The surgeon can select one or several elec-
trodes among the 22 available, using micro-switches. A saline solution pump is also connected
to the instrument and can be activated during RF ablation, in order to cool the electrodes.
2.1 Robotic Arm
The goal of the robotic arm is to deploy, position and retract the ablation device. A pre-
liminary phase is necessary and consists in stabilizing the atrium around the entry point of
the ablation device. To perform this, a trocar beforehand introduced and maintained with
a purse string into the atrial appendage, is connected to the robot. Consequently the robot
kinematic is designed with several mobilities used to align the trocar grip, before locking it
on the trocar (see figure 2 (left)). It consists in 3 translations and 3 rotations obtained by 4
roulette wheels, a vertical translation, an orientation joint and an arc circle translation which
have a rotation center located a few centimeters above the trocar grip. These mobilities are
only used at the beginning and at the end of the intervention. They are locked during the
deployment, positioning and retraction of the ablation device.
An other kinematic has been designed to move the ablation device into the atrium. This
kinematic is fixed on the arc circle translation and is composed of 4 motorized axes which
operate in position closed-loop (see figure 2 (right)). They are also driven by the axis control
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Figure 3: robot presentation (a,b), robot equipped of the ablation device (c)
computer. The ablation device is a large electrode mesh which has the particularity to be
retractable into a tube at the beginning and at the end of the operation and deployed once
introduced in the atrium through the trocar for the operation. The deployment/extraction
translation is used in that purpose while the z position translation for introduction. θ and
φ orientation joints and the z position translation are used to position and apply the device
onto the endocardium. The specifications of these axis are summarized in the following table.
Axis Range Resolution Speed
z 400 mm 0,1 mm 25 mm/s
deployment 95 mm 0,1 mm 1,2 mm/s
θ ±100◦ 1◦ 25◦/s
φ ±180◦ 1◦ 40◦/s
The robot arm has been developed according with these specifications. The different parts
of the robot are shown on figure 3. The ablation device, which is plugged in the robot (see
figure 3c), has been designed as a single use tool without actuators. The motors that activate
the deployment and θ orientation are outlying in the head. The device is described in the next
section.
2.2 Ablation device
The new concept for atrial fibrillation treatment reported here is related to the use of a special
ablation device (see figure 4). This device, so-called ”umbrella”, is a single use tool which has
an electrode mesh inlaid in a waterproof PDMS material1. It is plugged in the head once
1PolyDiMethylSiloxane, biocompatible silicone rubber from Nusil Technology - USA
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Figure 4: single use ablation device.
Figure 5: retracted/deployed umbrella.
the robot is placed and locked on the trocar. The umbrella is very flexible and is able to
be retracted in the supporting tube (see figure 5). Among the 22 independent electrodes
distributed on the umbrella surface, 6 have a small size and the others a large size.
Once introduced in the left atrium through the trocar and deployed, the umbrella is ori-
ented and positioned in a suitable contact with the endocardium surface (see figure 6). This
relative stiffness is obtained with pseudo-elastic shape memory alloy wires integrated in the
PDMS. By this way, the device can reach the hemisphere situated around the atrial appendage
but also the opposite hemisphere in the blood flow while the heart is beating. The 22 inde-
pendent electrodes are supposed to perform a part of the Cox-Maze ablation lines without
umbrella repositioning. The electrode configuration should permit to do all the lines with
ten or so consecutive positioning and reduce the ablation time in comparison with the actual
catheter technique. In order to improve the RF ablation effectiveness, the umbrella also in-
tegrates a water cooling system formed by a network of silicone (PDMS) pipes. An external
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Figure 6: umbrella applied around the appendage hemisphere and the opposite hemisphere.
Figure 7: trocar tube.
pump injects a saline solution, reaching each electrode on the umbrella’s surface by thin buses
(0.25 mm in diameter).
The surgical procedure is performed by positioning the RF electrode mesh on the atrial
endocardium using the degrees of freedom provided by the robot. According to the data ob-
tained by the navigation system i.e. the mesh current position, the anatomical landmarks and
the planned ablation lines, the umbrella is moved and applied in a previously defined area.
Then the surgeon activates, from among the 22 independent electrodes, those which fit the




For the correct and real-time umbrella tracking, a fixed reference point is needed. This point
is the left atrial appendage and must remain fully stabilized. We used a 220 mm in length
and 10 mm in diameter trocar fixed, by one hand, to the left atrial appendage with a purse
string and, by the other hand, to the robot trocar gripping. The ablation device is introduced
through it and can translate along and rotate around its axis (see figure 7). It is equipped of
silicone waterproof tips and of a silicone bleeding tube.
2.4 Control software
The surgeon controls the 4 ablation device mobilities through a specifically developed graph-
ical user interface (i.e. several intuitive windows sequentially given by the control software).
Thus he will follow the initialization procedure, the ablation device introduction and deploy-
ment. On the main windows he can activate a mobility gap and follow all the movements
during the positioning phase. The navigation system helps the surgeon to define which axis
must be activated to obtain a desired positioning.
The C++ program has two components. The low level component manage the closed loop
controls and the inter-system communications, using RTX2, which is a real time module. The
high level component is the surgeon interface and use a Windows process that exchanges data
with the RTX process. By this mean, the interface is user-friendly but also time deterministic,
allowing to ensure a reliable axes control.
2.5 Navigation system
A 3D echographic navigation system3 is used for locating, positioning and calculating the
umbrella pathway in the atrium. In this paper, navigation system details are not presented.
The purpose is to present the first in vitro and in vivo tests, concentrating on the performance
of the instrument. To date the navigation system has been tested but not used to guide the
surgeon during umbrella positioning in a beating heart. These first series of tests reported
here have been used to validate the mechanical system.
The navigation system gets axes positions from the axes control computer in real time. A
3D umbrella reconstruction is processed and displayed in a 3D environment including anatom-
ical landmarks. The landmarks are regularly updated with a transœsophagial ultrasound sys-
tem. The umbrella reconstruction and sensed image are also correlated. The system displays
the completed ablation lines. The details of the navigation are given by M. Hastenteufel(19).
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Figure 8: in vitro tests: RF ablation (left), echographic umbrella positioning (right).
Figure 9: ablation line made by two large electrodes (left), several electrodes (right).
3 In vitro tests
Several in vitro tests have been performed in order to validate instrument positioning, as well
as the effectiveness of the RF ablation. Some of these were performed in an entire veal heart
using an echographic system, others used ventricle pieces (see figure 8).
3.1 RF ablation tests
Trials consisted of testing the umbrella on a veal ventricule piece placed in warm water (see
figure 8 (left)). A saline solution was injected into the umbrella with a 100 ml/h flow, the
RF power was manually controlled under impedance measurement feedback and the ablation
duration was 300 s. The RF generator was model Neuro N 504. The ablation lines were cre-
ated using the two electrode types (see figure 9) : the large electrodes are 7 mm long, 0.5 mm
width and make lesions of 10 mm length, 3.5 mm wide and 3 mm deep. The small electrodes
2Ardence Inc. - Waltham (USA)
3developed by the Deutsches KrebsForschungsZentrum (DKFZ) - Division Medical and Biological Informat-
ics - Heidelberg (Germany)
4Stockert GmbH - Freiburg (Deutchland)
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Figure 10: ablation simulation: isotherm cut.
are 2 mm long, 0.5 mm width and make lesions having 3 mm length, 3.5 mm wide and 1.5 mm
deep. Ablation using a small electrode was always performed at the same time as a large one,
as the generator used did not allow measurement of the very high impedance of an individual
small electrode. When two adjacent electrodes were simultaneously fed, an entire overlapped
ablation lesion was obtained.
Other tests will be performed to define if one ablation shot can be achieved using more
than two electrodes simultaneously. Currently the ablation depth is too small, i.e. around 3
mm. Obtaining transmural ablation on fibrillating atria normally requires a 4 mm minimum
depth. To simulate and understand RF behaviour, a model describing the electrode effect on
a tissue has been built. It involves modeling the tissue as a conductive medium, subject to an
electric potential. Potential distribution V is given by the Laplace equation:
−div(γ−−−−→gradV ) = 0 (1)
where γ is the tissue electrical conductivity. The temperature distribution T in permanent
regime is calculated using the bioheat equation(20):
λ div T + γ (gradV )2 = 0 (2)
where λ is the tissue thermal conductivity.
This model is processed with Comsol5 software. The parameter values are obtained from
tungjitkusolmun(20). A good accuracy has been observed between the model and reality. The
ablation depth find by the model is 3, 1 mm, which is similar to the experiments. Furthermore,
5Comsol Inc. - Los Angeles (USA)
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the simulation has shown that the convection around the electrode has a big influence on the
ablation depth. The depth reaches 7 mm when a forced convection is applied (see figure 10).
According to the simulation results, a new prototype of a single electrode, reproducing a small
part of the umbrella, has been built and tested. In this design, a forced cooling canal has been
placed over the electrode. The cooling fluid circulation has been set to more than 3600 ml/h in
a closed loop circuit. The achieved ablation depth measured on ventricular pieces were about
5 mm in comparison with 3 mm in the case of initial cooling. The new closed loop cooling
system has to be designed and then integrated into the umbrella. All the results presented in
the next section have been done without modifications of the ablation device cooling system.
To date, the design modifications of the umbrella haven’t started.
3.2 Umbrella positioning
Mechanical flexibility is very important for correct umbrella deployment as well as ensuring a
good contact between the electrodes and the atrial endocardium during the RF ablation pro-
cess. The flexibility is provided by several pseudo-elastic shape memory alloy wires, moulded
in the PDMS. These Nitinol 6% strain wires allow an extreme curvature and a moderate pres-
sure in the atrium. The tests done in a veal atrium demonstrated the ability of the instrument
to fit the curvature (see figure 8). In case of bad contact, the impedance measurement per-
formed by the RF generator warns the RF operator, in real time, of the need to reposition
the umbrella.
4 In vivo tests
The first in vivo study was performed at the animal lab of the department of intensive care
medicine6. Animals received humane care in compliance with the Guide for the Care and Use
of Laboratory Animals. The goal was to evaluate the instrument and the robotic system, in
real conditions.
4.1 Operation description
Under general anesthesia, a sheep was placed in right lateral decubitus. A left thoracotomy
was performed followed by a small pericardial window. The left atrial appendage was easily
identified and a purse string (Prole`ne 4/0) was sutured at the base of it. After heparinization,
the trocar was inserted into the left atrium via the purse string. Then, the robot base was
brought and adjusted to the correct position, in order to fix the trocar on it. The sterilized
ablation device was plugged in the robot head and the introduction procedure was performed
(see figure 11). Due to a minor design error, interference between the trocar and the device
damaged the silicone cap placed at the umbrella base, leading to a saline solution leakage into
the ablation device mechanism. In spite of this failure, the procedure continued without any
consequences for the sheep. The umbrella was deployed successfully and moved inside the left
atrium.
6Universite´ Libre de Bruxelles, Belgium : director Prof J.L. Vincent MD, PhD
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Figure 11: in vivo tests: instrument unplugged (left), umbrella deployed in the atrium (right).
Transœsophagel ultrasound images were acquired. It was difficult to localize the umbrella
and anatomical landmarks with the poor image quality provided by the echograph. This ap-
peared to be due to variation between sheep and human anatomy. This problem prevented us
from positioning the instrument in relation to the anatomical landmarks, and hence perform-
ing any RF ablation. At this point, further testing of navigation tasks were postponed to the
next set of animal trials.
According to the surgical protocol, the instrument was removed, in a open heart procedure
(after the animal sacrifice). Some fibrin deposit could be found in the instrument’s surface.
During the procedure, the sheep remained clinically stable, under general anesthesia for more
than 2 hours. These first tests showed that the instrument can be safely introduced in a
beating and stabilized left atrium.
4.2 Perspectives
The tests showed that the ablation device and the robot are mechanically validated. Some
minor design changes are required to avoid interference and leakages. The design of the new
umbrella, with a forced closed loop cooling system, need to be carried out. Some extra tests
are also needed to define if there is a coagulating effect on the surface of the instrument.
5 Conclusion
This new robotic instrument for Beating Heart Atrial Fibrillation Treatment should open a
new approach to surgical intervention. With reduced invasivity this method should offer to
the surgeon the possibility of using an original instrument specially designed for making abla-
tion lines in the left atrium. Because of its specific purpose, the instrument is positioned and
activated by a robot, able to control precisely the pathways desired by the surgeon.
13
The development of the instrument is in progress. At this time, the first in vitro and
in vivo functional tests have been performed. These tests validated the technological choices
made for the umbrella itself and for the peripheral elements used to introduce, to orient and to
cool the electrode mesh. Minor engineering reviews are in progress. Later, some extra in vivo
and in vitro will be performed, in order to validate the integration of the entire system. A less
invasive procedure using thoracoscopy must be studied in order to avoid the left thoracotomy.
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